Sometimes Even Superheroes

Need a little help!

Register Today

and receive a Fucidin® Clinic Kit

Fucidin®

At a Glance

Fucidin® is Europe's top selling topical antibiotic brand.2 The unique molecular structure of fusidic acid allows it to penetrate deep into the skin, achieving antimicrobial concentration even at the deep layers of the dermis.1,3,4

With good efficacy and low resistance of Staphylococcus aureus,5 Fucidin delivers high clinical response rates in a range of bacterial skin infections.1,6

Fucidin® Mode of Action
Fucidin® reaches deep-seated infections
Fucidin® covers a wide range of skin infections

Why Prescribe

Fucidin®?

Europe's top selling topical antibiotic brand.2 With low rates of allergic reactions and other adverse events,7 Fucidin® is recommended for use in treatment guidelines all around the world.8-15
Fucidin®'s unique structure penetrates deep into the skin where it is effective against bacteria at deep layers of the dermis.1,3,4
Fucidin® is highly effective against a wide range of primary and secondary infections.1,6 Over 90% of patients with skin and soft tissue infections achieve good clinical outcomes.18-21
Fucidin® has low antibiotic resistance rate. No cross resistance with other antibiotics has been observed.1 S. aureus resistance to Fucidin® is low.5,7
Trusted
Penetration
Effective
Low Resistance

Kick Staphy

Out!

Staphylococcus aureus is a key pathogen in skin and soft-tissue infections (SSTI)16,17 such as:
Controlling S. aureus is crucial in treating these conditions.16 Fucidin® is:

  • A potent antimicrobial, with low resistance to Staphylococcus aureus5
  • Fast acting, with a mean healing time of 7.1 days.18

Over 90% of patients with SSTI achieve good results with Fucidin®.18-21

The Fucidin® Family

Select a group to compare

Plain Antibiotic

Antibiotic-Steroid Combination

Active Ingredients

Fusidic acid 20mg/g,
hydrocortisone acetate 10 mg/g

Pack Size
5g

Appropriate in cases where a milder corticosteroid is indicated, and on the face and on children's skin24

Active Ingredients

Fusidic acid 20mg/g, betamethasone as valerate 1mg/g

Pack Size
5g

Indicated in inflammatory dermatoses where bacterial infection is present or likely to occur25

Active Ingredients

Fusidic acid 20mg/g

Pack Size
5g, 15g

Primary & Secondary
skin infections23

Active Ingredients

Sodium fusidate 20mg/g

Pack Size
5g,15 g

Suitable when more occlusive
effect is needed (wet wounds)22

About LEO Pharma

LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline,
a wide range of therapies and a pioneering spirit.

Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to
advance the science of dermatology, setting new standards of care for people with skin conditions.

LEO Pharma is headquartered in Denmark, with a global team of more than 5,500 people, serving 80 million patients in
130 countries. In 2017, the company generated net sales of 1.4 billion euro.

 
Our Mission

We help people achieve healthy skin

Our Vision

We are the preferred dermatology care partner improving people's lives around the world

REFERENCES:

  1. Schofer H & Simonsen L. Eur J Dermatol 2010;20:6-15.
  2. IMS MAT Q3’18 (ATC D06A Value and Volume Market Share) - Europe Region
  3. Knight AG et al. Br J Dermatol 1969;81(Suppl 4):88-91.
  4. Stuttgen G & Bauer E. Drug Res 1988;38:730-735.
  5. Stratchounski LS, Dekhnich AV, Kretchikov VA, et al. J Chemother.2005;17:54–60.
  6. Spelman D. J Antimicrob Agents 1999; 12(Suppl 2):S59-S66.
  7. Long BH. Acta Derm Venereol 2008;Suppl 216:14-20.
  8. Primary Care Dermatology Society & British Association of Dermatologists. Guidelines for the management of atopic eczema. Available at:
    http://www.pcds.org.uk/images/stories/pcdsbad-eczema.pdf. Accessed on 11/1/2019.
  9. Wollenberg A et al. J Eur Acad Dermatol Venereol. 2016;30(5):729-747.
  10. NICE Guidelines. Treating atopic eczema in children aged 12 and under. Available at: https://pathways.nice.org.uk/pathways/eczema#path=view%3A/pathways/eczema/ treating-atopic-eczema-in-children-aged-12-and-under.xml&content=view-node%3Anodes-bacterial-infection Accessed on 11/1/2019.
  11. NHS Guidelines. Guidelines for the management of eczema in children under 12 years. Available at: http://www.southwarkdermatology.co.uk/website/X20213/-les/ Guidelines%20for%20the%20management%20of%20eczema%20in%20children%20under%2012yrs%20(Final_July_2015).pdf Accessed on 11/1/2019
  12. Tay YK et al. Ann Acad Med Singapore. 2016;45:439-450.
  13. Katayama I et al. Allergology International. 2017;66:230-247.
  14. Werfel T et al. Allergo J Int. 2016;25:82-95.
  15. Galli E et al. Ital J Pediatr. 2016;42:26.
  16. Rigopoulos D & Larios M. Acta Derm Venereol 2008; Suppl 216: 7–13.
  17. Mistry RD. Pediatric Clinics 2013;60(5):1063-1082.
  18. Pakrooh H. Curr Med Res Opin. 1978;5(4):289-94.
  19. Langdon CG, Mahapatra KS. Curr Ther Res. 1990;48(1):174-80.
  20. Baldwin RJT, Cran¬eld R. Br J Clin Pract. 1981;35(4):157-60.
  21. White DG et al. J Infect. 1989;18:221-29.
  22. Fucidin Ointment Prescribing Information
  23. Fucidin Cream Prescribing Information
  24. Fucidin H Prescribing Information
  25. Fucicort Cream Prescribing Information

Declaration

For Philippine Healthcare
Professionals Only

The information on the site you are trying to enter is intended exclusively for Philippine Healthcare Professionals, who may prescribe, purchase, supply or administer medications based on regulations approved by the Philippine government and is not intended for the general public product and is not intended for the general public.

You must accept this option first